Cargando…

Herd Protection against Meningococcal Disease through Vaccination

Reduction in the transmission of Neisseria meningitidis within a population results in fewer invasive disease cases. Vaccination with meningococcal vaccines composed of high weight capsular polysaccharide without carrier proteins has minimal effect against carriage or the acquisition of carriage. Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Stephen A., Borrow, Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693901/ https://www.ncbi.nlm.nih.gov/pubmed/33126756 http://dx.doi.org/10.3390/microorganisms8111675

Ejemplares similares

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

A comparison of national vaccination policies to prevent serogroup B meningococcal disease
por: Sulis, Giorgia, et al.
Publicado: (2022)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Findlow, Jamie, et al.
Publicado: (2019)

Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens
por: Clark, Stephen A., et al.
Publicado: (2014)

Meningococcal infections among refugees and immigrants: silent threats of past, present and future
por: Dinleyici, Ener Cagri, et al.
Publicado: (2020)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Parikh, Sydel R., et al.
Publicado: (2016)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

An evaluation of emerging vaccines for childhood meningococcal disease
por: Choudhuri, Debajeet, et al.
Publicado: (2011)

Importance of circulating antibodies in protection against meningococcal disease
por: Erlich, Kim S., et al.
Publicado: (2012)

Protection against invasive meningococcal disease and vaccination policy in the Netherlands
por: Ohm, M, et al.
Publicado: (2022)

Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
por: Elias, Johannes, et al.
Publicado: (2013)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Ladhani, Shamez N., et al.
Publicado: (2016)

Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review
por: Alderson, Mark R., et al.
Publicado: (2022)

Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa
por: Okwo-Bele, Jean-Marie, et al.
Publicado: (2015)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

Meningococcal conjugate vaccines: optimizing global impact
por: Terranella, Andrew, et al.
Publicado: (2011)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

A meningococcal B vaccine induces cross-protection against gonorrhea
por: Azze, Rolando Felipe Ochoa
Publicado: (2019)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017)
por: Ladhani, Shamez N., et al.
Publicado: (2019)

Protecting the Herd: Why Pharmacists Matter in Mass Vaccination
por: Lee, Lois, et al.
Publicado: (2020)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Meningococcal Vaccination:: An Update on Meningococcal Vaccine Recommendations for the Primary Care Physician
por: Nichols, Justin, et al.
Publicado: (2022)

Evaluation of Dried Blood and Cerebrospinal Fluid Filter Paper Spots for Storing and Transporting Clinical Material for the Molecular Diagnosis of Invasive Meningococcal Disease
por: Kwambana-Adams, Brenda A., et al.
Publicado: (2022)

Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
por: Johnson, Steven, et al.
Publicado: (2012)

Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines
por: Cayrou, Caroline, et al.
Publicado: (2018)

The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
por: Kugelberg, Elisabeth, et al.
Publicado: (2010)

Impact of vaccination on meningococcal epidemiology
por: Stefanelli, Paola, et al.
Publicado: (2015)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269
por: Stella, Maria, et al.
Publicado: (2019)

Meningococcal Disease Section 2: Epidemiology and Vaccination of Meningococcal Disease in Northern Ireland: MeningoNI Forum
por: Millar, BC, et al.
Publicado: (2018)

The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection
por: Heckels, John E, et al.
Publicado: (2010)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination
por: Burman, Cynthia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qjs6b5po88823qk8kvafla2dr7